Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder

doi:10.1001/jamapediatrics.2017.1269

Comment

. 2017 Aug 1;171(8):729-731.

doi: 10.1001/jamapediatrics.2017.1269.

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder

Brendan Saloner^{1

2}, Kenneth A Feder², Noa Krawczyk²

Affiliations

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
² Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.

PMID: 28628699
PMCID: PMC6007012
DOI: 10.1001/jamapediatrics.2017.1269

Comment

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder

Brendan Saloner et al. JAMA Pediatr. 2017.

. 2017 Aug 1;171(8):729-731.

doi: 10.1001/jamapediatrics.2017.1269.

Authors

Brendan Saloner^{1

2}, Kenneth A Feder², Noa Krawczyk²

Affiliations

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
² Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.

PMID: 28628699
PMCID: PMC6007012
DOI: 10.1001/jamapediatrics.2017.1269

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Comment on

Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Hadland SE, et al. JAMA Pediatr. 2017 Aug 1;171(8):747-755. doi: 10.1001/jamapediatrics.2017.0745. JAMA Pediatr. 2017. PMID: 28628701 Free PMC article.

Cited by

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims.
Xu KY, Huang V, Williams AR, Martin CE, Bazazi AR, Grucza RA. Xu KY, et al. Drug Alcohol Depend Rep. 2023 Oct 20;9:100195. doi: 10.1016/j.dadr.2023.100195. eCollection 2023 Dec. Drug Alcohol Depend Rep. 2023. PMID: 38023343 Free PMC article.
Health care use and cost of treatment for adolescents and young adults with opioid use disorder.
Orme S, Zarkin GA, Dunlap LJ, Monico LB, Gryczynski J, Fishman MJ, Schwartz RP, O'Grady KE, Mitchell SG. Orme S, et al. J Subst Use Addict Treat. 2023 Nov;154:209137. doi: 10.1016/j.josat.2023.209137. Epub 2023 Aug 7. J Subst Use Addict Treat. 2023. PMID: 37558183 Free PMC article. Clinical Trial.
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015-2020.
Terranella A, Guy GP, Mikosz C. Terranella A, et al. Pediatrics. 2023 Feb 1;151(2):e2022058755. doi: 10.1542/peds.2022-058755. Pediatrics. 2023. PMID: 36691760 Free PMC article.
"We need to build a better bridge": findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youth.
Marchand K, Fogarty O, Pellatt KM, Vig K, Melnychuk J, Katan C, Khan F, Turuba R, Kongnetiman L, Tallon C, Fairbank J, Mathias S, Barbic S. Marchand K, et al. Harm Reduct J. 2022 Apr 17;19(1):37. doi: 10.1186/s12954-022-00623-7. Harm Reduct J. 2022. PMID: 35430803 Free PMC article.
Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
Pilarinos A, Bromberg DJ, Karamouzian M. Pilarinos A, et al. JAMA Pediatr. 2022 Mar 1;176(3):304-311. doi: 10.1001/jamapediatrics.2021.4606. JAMA Pediatr. 2022. PMID: 34870707 Free PMC article.

See all "Cited by" articles

References

1. Kaiser Family Foundation. [Accessed March 30, 2017];State Health Facts: opioid overdose deaths by age group. 2016 http://kff.org/other/state-indicator/opioid-overdose-deaths-by-age-group....
1. Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. - PubMed
1. Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. doi: 10.1001/jamapediatrics.2017.0745. [published online June 19, 2017] - DOI - PMC - PubMed
1. Minozzi S, Amato L, Bellisario C, Davoli M. Maintenance treatments for opiate-dependent adolescents. Cochrane Database Syst Rev. 2014;(6):CD007210. - PMC - PubMed
1. Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

[1] Kaiser Family Foundation. [Accessed March 30, 2017];State Health Facts: opioid overdose deaths by age group. 2016 http://kff.org/other/state-indicator/opioid-overdose-deaths-by-age-group....

[2] Kaiser Family Foundation. [Accessed March 30, 2017];State Health Facts: opioid overdose deaths by age group. 2016 http://kff.org/other/state-indicator/opioid-overdose-deaths-by-age-group....

[3] Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. - PubMed

[4] Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066. - PubMed

[5] Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. doi: 10.1001/jamapediatrics.2017.0745. [published online June 19, 2017] - DOI - PMC - PubMed

[6] Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. doi: 10.1001/jamapediatrics.2017.0745. [published online June 19, 2017] - DOI - PMC - PubMed

[7] Minozzi S, Amato L, Bellisario C, Davoli M. Maintenance treatments for opiate-dependent adolescents. Cochrane Database Syst Rev. 2014;(6):CD007210. - PMC - PubMed

[8] Minozzi S, Amato L, Bellisario C, Davoli M. Maintenance treatments for opiate-dependent adolescents. Cochrane Database Syst Rev. 2014;(6):CD007210. - PMC - PubMed

[9] Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. - PubMed

[10] Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder

Affiliations

Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous